HCPCS Level II · Outpatient PPS (temporary codes)
C9169Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Terminated 12/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9169
C9169 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram.
It was added to HCPCS effective 10/01/2024, and its current record took effect 01/01/2025.
It was terminated on 12/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, nogapendekin pmln 1 mcg
- Date added
- 10/01/2024
- Action effective
- 01/01/2025
- Termination date
- 12/31/2024
- BETOS
- O1E
Related C91xx codes
Common questions about C9169
Is HCPCS C9169 still valid?
- No. C9169 was terminated on 12/31/2024.
Does Medicare cover C9169?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.